Collard Craig A bought HRTX
January 31, 2025 · Form 4 insider transaction
Collard Craig A bought 1,113,240 shares of Heron Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,113,240
Price
$0.00
Total value
N/A
InsiderCollard Craig A
RoleOfficer, Director
SecurityEmployee Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 31, 2025
Filing dateFebruary 4, 2025
Shares owned after1,113,240
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (January 31, 2025).